PETMEDIX

• 72110 - Research and experimental development on biotechnology

PetMedix is creating the treatment solutions to help our pets. By taking the experience of our scientific team, and decades of human clinical research, we are building platforms that can develop fully species-specific, naturally-generated therapeutic antibodies. We will use these platforms to develop our own veterinary medicines to target some of the most important underserved clinical areas, which not only would have critically beneficial healthcare impact, they also represent excellent market opportunities... PetMedix is delivering the next generation of proven monoclonal antibody technology to provide unprecedented therapeutic options for pets... PetMedix leverages an experienced scientific team and decades of human clinical research to develop fully species-specific, naturally generated therapeutic antibodies for pets. Here are some key moments in the company's development and growth.

Also known as: PETMEDIX LTD

Registration numbers: 11095804 (CH)

Primary location: Cambridge United Kingdom